G. Loss

JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma

Engineered skin bacteria induce antitumor T cell responses against melanoma

Major histocompatibility complex class II-restricted presentation of an internally synthesized antigen displays cell-type variability and segregates from the exogenous class II and endogenous class I presentation pathways.

Invariant chain retains MHC class II molecules in the endocytic pathway